Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial
PaperCitations, authors & open-access status
Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 87 citations, 2023 year and closed oa status.
87
Citations
2023
Year
closed
OA Status